coronaviru
cov
diseas
caus
sever
acut
respiratori
syndrom
sar
also
known
threaten
global
public
health
social
stabil
econom
develop
meet
challeng
articl
discuss
advanc
research
develop
neutral
antibodi
nab
prevent
treatment
infect
human
cov
three
emerg
highli
pathogen
human
cov
sarscov
middl
east
respiratori
syndrom
mer
cov
viru
previous
name
world
health
organ
also
known
atyp
pneumonia
sar
first
report
guangdong
provinc
china
late
sar
caus
global
pandem
approxim
case
fatal
rate
cfr
sarscov
circul
human
sinc
merscov
first
report
saudi
arabia
continu
infect
human
limit
humantohuman
transmiss
lead
cfr
approxim
countri
accord
recent
report
sarscov
merscov
zoonot
virus
use
bat
natur
reservoir
transmit
bat
intermedi
host
eg
palm
civet
sarscov
dromedari
camel
merscov
lead
infect
human
differ
sarscov
merscov
first
report
wuhan
china
decemb
character
rapid
spread
virul
humantohuman
transmiss
result
confirm
case
includ
death
cfr
particularli
wuhan
china
least
countri
territori
area
march
vaccin
treatment
horizon
research
explor
variou
medic
intervent
includ
nab
control
continu
spread
global
pandem
also
zoonot
viru
bat
natur
reservoir
intermedi
host
identifi
infect
mainli
result
pneumonia
upperlow
respiratori
tract
infect
fever
cough
two
major
clinic
symptom
other
includ
short
breath
muscl
pain
myalgia
fatigu
confus
headach
sore
throat
even
acut
respiratori
distress
syndrom
lead
respiratori
multiorgan
failur
elderli
peopl
underli
comorbid
diabet
hypertens
cardiovascular
diseas
infect
may
result
sever
fatal
respiratori
diseas
far
effect
children
gener
mild
viru
transmit
respiratori
droplet
close
contact
infect
surfac
object
detect
multipl
sampl
includ
saliva
stool
blood
develop
vaccin
therapeut
must
understand
behavior
key
protein
similar
sarscov
merscov
envelop
singlestrand
posit
sens
rna
viru
belong
betacov
genera
famili
coronavirida
genom
emerg
pathogen
human
cov
encod
four
major
structur
protein
spike
envelop
e
membran
nucleocapsid
n
approxim
nonstructur
protein
five
eight
accessori
protein
among
protein
play
essenti
role
viral
attach
fusion
entri
transmiss
compris
ntermin
subunit
respons
virusreceptor
bind
ctermin
subunit
respons
viruscel
membran
fusion
divid
ntermin
domain
ntd
receptorbind
domain
rbd
sarscov
bind
angiotensinconvert
enzym
merscov
bind
dipeptidyl
peptidas
receptor
host
cell
express
eg
pneumocyt
enterocyt
eg
liver
lung
cell
includ
phylogenet
close
relat
sarscov
share
approxim
genom
sequenc
ident
infect
cov
first
bind
host
cell
interact
cell
membran
receptor
trigger
conform
chang
subunit
result
viru
fusion
entri
target
cell
see
human
cov
life
cycl
figur
viru
nab
induc
vaccin
infect
viru
play
crucial
role
control
viral
infect
current
develop
sarscovand
merscovspecif
nab
includ
monoclon
antibodi
mab
function
antigenbind
fragment
fab
singlechain
variabl
region
fragment
scfv
singledomain
antibodi
nanobodi
nb
target
region
block
trend
immunolog
month
vol
xx
xx
trend
immunolog
bind
rbd
respect
receptor
interf
membran
fusion
entri
host
cell
thu
inhibit
viral
infect
put
target
mechan
sarscov
merscov
nab
shown
figur
repres
sarscov
merscov
rbdspecif
nab
summar
tabl
nab
report
herein
introduc
sarscovand
merscovspecif
nab
context
potenti
crossneutr
activ
infect
current
develop
antisarscov
nab
target
viral
protein
target
rbd
target
region
subunit
proteolyt
cleavag
site
exampl
human
neutral
mab
isol
sarscovinfect
individu
neutral
human
palm
civet
sarscov
infect
interact
rbd
thu
block
bind
viral
rbd
cellular
receptor
human
mab
crossneutr
activ
multipl
human
palm
civet
raccoon
dog
sarscov
infecti
clone
protect
mice
four
differ
homolog
heterolog
sarscov
strain
human
nab
scfv
mab
neutral
sarscov
infect
block
interact
although
protect
efficaci
yet
report
varieti
sarscov
rbdspecif
mous
neutral
mab
suffici
potent
block
bind
thu
neutral
viral
infect
cell
despit
strong
neutral
activ
andor
protect
cell
anim
model
none
sarscov
nab
ever
evalu
clinic
studi
thu
determin
potenti
crossneutr
activ
infect
studi
vigor
undertaken
number
merscovspecif
nab
report
target
rbd
protein
recogn
epitop
region
subunit
among
nab
human
mab
fab
isol
human
human
mab
h
mous
mab
isol
mice
nb
isol
dromedari
camel
llama
recogn
epitop
rbd
demonstr
neutral
pseudotyp
andor
live
merscov
sever
humanhuman
mab
nb
protect
mice
rabbit
common
marmoset
merscov
infect
far
one
merscov
nab
isol
transchromosom
cattl
evalu
phase
trial
ii
nab
gone
clinic
trial
suggest
urgenc
develop
nab
potenti
crossneutr
activ
infect
current
polyclon
antibodi
recov
patient
use
treat
infect
neutral
mab
report
research
work
hard
develop
mab
andor
function
fragment
put
prophylact
therapeut
agent
prevent
treat
antibodi
produc
next
step
involv
vitro
test
neutral
andor
crossneutr
activ
vivo
evalu
avail
anim
model
protect
efficaci
preclin
studi
clinic
trial
test
safeti
efficaci
approv
clinic
applic
therefor
may
take
one
sever
year
neutral
mab
fragment
readi
human
use
howev
sinc
close
relat
sarscov
sinc
protein
high
sequenc
ident
research
attempt
discov
sarscov
nab
potenti
crossreact
andor
crossneutr
activ
infect
notabl
sarscov
rbdspecif
human
neutral
mab
could
bind
rbd
high
affin
recogn
epitop
rbd
overlap
site
addit
sera
convalesc
sar
patient
anim
specif
sarscov
may
crossneutr
infect
reduc
proteinmedi
entri
cov
rbdbase
vaccin
might
eventu
prevent
sarscov
infect
also
possibl
sarscov
rbdtarget
nab
might
appli
prophylaxi
treatment
infect
current
absenc
vaccin
antibodi
howev
robust
test
lie
ahead
continu
infect
peopl
global
concomit
urgenc
develop
effect
nab
prophylact
therapeut
agent
prevent
treat
infect
control
spread
studi
sarscov
merscov
demonstr
mani
fragment
rbd
protein
use
target
develop
nab
still
rbdspecif
antibodi
greater
potenc
neutral
infect
diverg
viru
strain
suggest
rbd
also
serv
import
target
develop
potent
specif
nab
cocktail
compris
antibodi
specif
rbd
region
protein
may
improv
breadth
potenc
nab
escapemut
strain
human
sera
convalesc
patient
use
treat
lesson
learn
sar
show
nonnab
target
nonrbd
region
protein
may
caus
antibodydepend
enhanc
ade
effect
viral
infect
diseas
well
harm
immun
respons
posit
note
antisarscov
nab
shown
crossreact
crossneutr
activ
infect
vitro
thu
overal
research
sarscovand
merscovspecif
nab
provid
import
guidelin
rapid
design
develop
nab
